---
title: "Arcline-backed Arxis reveals revenue surge in US IPO filing"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280379389.md"
datetime: "2026-03-24T22:49:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280379389.md)
  - [en](https://longbridge.com/en/news/280379389.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280379389.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280379389.md) | [繁體中文](https://longbridge.com/zh-HK/news/280379389.md)


# Arcline-backed Arxis reveals revenue surge in US IPO filing

March 24 (Reuters) - Private equity firm Arcline-backed Arxis revealed its annual revenue more than doubled in its filing for a U.S. initial public offering on Tuesday, underscoring strong sponsor appetite to test the listing market amid surging demand for aerospace and defense parts.

The filing comes as aerospace and defense companies attract renewed investor interest, supported by rising global defense spending and resilient commercial aviation demand.

Arxis, which produces parts such as flight control bearings and engine fire seals and serves aerospace and defense original equipment manufacturers, said it had about 5,750 employees as of December 31, 2025.

Arcline, which specializes in industrial investments and currently controls Arxis, is expected to remain a long-term investor in the company following the IPO.

The private equity firm struck a deal with KKR (KKR.N) in November to acquire aerospace and defense hardware maker Novaria Group for $2.2 billion.

Arxis reported a net income of about $46 million on revenue of $1.59 billion in 2025, compared with a loss of $55.5 million on revenue of $743 million in 2024.

The company said it has applied to list its stock on the Nasdaq exchange under the symbol “ARXS.”

Goldman Sachs, Morgan Stanley and Jefferies were among the joint bookrunning managers for the offering.

## 相关资讯与研究

- [Royalty Pharma Leans Into R&D And AI To Shape Future Royalties](https://longbridge.com/zh-CN/news/281693786.md)
- [First Shanghai Securities Reaffirms Their Buy Rating on China International Capital (CNICF)](https://longbridge.com/zh-CN/news/281701888.md)
- [Rusoro Mining (CVE:RML) Director Sells 60,000 Shares](https://longbridge.com/zh-CN/news/281694931.md)
- [Should Record 2025 Output and 100% U.S. Reserve Replacement Require Action From Freehold (TSX:FRU) Investors?](https://longbridge.com/zh-CN/news/281696598.md)
- [Is Netflix a Buy After Its Most Recent Price Hike?](https://longbridge.com/zh-CN/news/281711609.md)